Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01248676
Other study ID # Cindy Multi-Language Online
Secondary ID
Status Completed
Phase N/A
First received November 18, 2010
Last updated August 15, 2011
Start date December 2010
Est. completion date April 2011

Study information

Verified date August 2011
Source Sunnybrook Health Sciences Centre
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if multi-language patients will find the multi-language capabilities of the online modules useful for better understanding of the general information regarding radiation therapy.


Description:

Research shows that treatment-related information is the most important informational need of cancer patients and online media sources are gaining popularity as a cancer communication method. It is important to know whether having multi-language online education modules are usable for and beneficial to the multicultural cancer patient population at Sunnybrook Hospital, given that recent research suggests that this cancer population in general faces many barriers to effective online cancer communication. Approximately 10 new patients from the radiation oncology clinic at Sunnybrook Hospital will be screened to participate in the study. Usability testing will involve a combination of interviewing, observation, think-aloud methodology and a short survey.Results will be analyzed by assessing the percentage of patients identifying with a certain level of the Likert scale on the survey as well as through content analysis of responses to the interview and open-ended survey questions.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date April 2011
Est. primary completion date April 2011
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- first/second language in one of the module languages with the ability to understand and communicate English to an understandable degree, basic computer skills, and the ability to complete 20-30 minutes of testing.

Exclusion Criteria:

- inability to participate in 20-30 minutes of usability testing.

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
Multi-language Online Patient Education Module in addition to standard Patient Teaching
Patients are usually be given a 5-10 minute "new patient teaching" before their radiation therapy simulation and planning appointment and before their first radiation therapy treatment appointment. Patients will be asked to view an online patient education module before their radiation therapy simulation and planning appointment or before their first radiation therapy treatment appointment. Then patients will be asked to participate in an interview session and fill out a survey (attached). They will still receive "new patient teaching" from the therapists before their radiation therapy simulation and planning or radiation therapy treatment appointment.

Locations

Country Name City State
Canada Odette Cancer Centre at Sunnybrook Health Sciences Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Sunnybrook Health Sciences Centre

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patients will be asked to give their rating (Likert scale) on the usefulness of the information on the patient education site with regard to their upcoming radiation simulation and treatment. Within one month of patients initial consultation with the Radiation Oncologist No
Secondary Patients will be asked to give their rating (Likert scale) on how easily the online patient education module is to navigate. Within one month of patients initial consultation with the Radiation Oncologist No
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients